Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

TA-CD enters phase IIa cocaine administration study

April 16, 2003

Evidence for potential of SB-277011-A in drug dependence and psychosis

April 11, 2003

HE-2100 protects nonhuman primates from effects of radiation exposure

April 9, 2003

Enrollment complete in phase III trial of Vivitrex in alcohol dependence

April 3, 2003

Large Scale Biology and U. of Arkansas enter agreement for drug intervention therapy

March 5, 2003

5-HT1A agonists with utility in the treatment of opioid dependence

March 5, 2003

Potential use of selegiline hydrochloride in promoting smoking cessation

March 4, 2003

NicVAX phase I/II trial begins enrollment

Feb. 21, 2003

U. of Michigan claims dopamine receptor modulators for cocaine abuse and other disorders

Jan. 29, 2003

Xenova buys out ImmuLogic's interests in TA-CD and TA-NIC programs

Jan. 17, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...